Amer Syed

Amer Syed, MD, FACP, is a seasoned medical professional with a diverse background in both clinical practice and pharmaceutical education. Currently serving as a Medical Director at Lutheran Pace Life since 2019, Amer Syed oversees a Medicare/Medicaid Capitated Program, focusing on Utilization Management, Chronic Care Management, and Transition of Care. Amer Syed's extensive speaking engagements include national roles with Salix Pharmaceuticals, Biohaven Pharmaceuticals, Amgen, Eli Lilly and Company, AstraZeneca, Pfizer, and Abbott, where education efforts center around various healthcare topics and product mechanisms. As Chief Executive Officer at Hudson Medical Group since 2008, Amer Syed combines clinical expertise with management skills, further enhanced by an MBA from Rutgers Business School and a Doctor of Medicine degree from Seton Hall University.